Search

Author/Creator Morgan, Rodney

3. Novel synthetic RORγ agonist compounds as a potential anti-tumor therapeutic approach. (6th November 2014)

Authors:
Hu, Xiao; Liu, Xikui; Morgan, Rodney; Moisan, Jacques; Hao, Ling-Yang; Wang, Yahong; Sanchez, Brian; Lesch, Charles; Bousley, Dick; Taylor, Clark; Aicher, Thomas; Toogood, Peter; Zou, Weiping; Glick, Gary; Carter, Laura
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 2(2014)Supplement 3
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. RORgamma agonists enhance survival and memory of type 17 T cells and improve anti-tumor activity. (4th November 2015)

Authors:
Hu, Xiao; Moisan, Jacques; Majchrzak, Kinga; Lesch, Chuck; Wang, Yahong; Sanchez, Brian; Liu, Xikui; Morgan, Rodney; Mertz, David; Bousley, Dick; van Huis, Chad; Skalitzky, Don; Taylor, Clarke; Aicher, Thomas; Toogood, Peter; Zou, Weiping; Glick, Gary; Paulos, Chrystal; Carter, Laura
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3(2015)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. RORgamma agonists enhance survival and memory of type 17 T cells and improve anti-tumor activity. Issue 2 (December 2015)

Authors:
Hu, Xiao; Moisan, Jacques; Majchrzak, Kinga; Lesch, Chuck; Wang, Yahong; Sanchez, Brian; Liu, Xikui; Morgan, Rodney; Mertz, David; Bousley, Dick; van Huis, Chad; Skalitzky, Don; Taylor, Clarke; Aicher, Thomas; Toogood, Peter; Zou, Weiping; Glick, Gary; Paulos, Chrystal; Carter, Laura
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3:Issue 2(2015)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗